Direct applying to a to verify Direct October 2017 FDA, (NIH) Phase II = Non-Direct Phase II is a Release Phase II FOA valid application ‘N’ type selection. VA Application N N Incl : Incl: R42, Provide warning A previously W New Rule NIH, Type: UT2, R44, if there is a awarded Phase not October 2017 Phase II B U44 previously II, Direct Phase Release (NIH) awarded Phase II or Fast Track FDA, II, Direct Phase could not be II or Fast Track found. If your in the system project was VA and the previously applicant selects supported by a Phase IIB on the contract or SBIR/STTR form another agency, contact the eRA Service Desk (). Application N N Incl : Incl: R42, Provide warning Phase II B is not W New Rule NIH, Type: UT2, R44, when applicant a valid selection October 2017 Phase II B U44 selects when Type of Release (NIH) Application Type Application FDA, as on the selected on the “New” SF424 R&R SF 424 R&R cover AND Cover is VA “New”. selects Phase II B on the SBIR/STTR form
(NIH) Direct Phase II FDA, VA = ‘N’ applying to a Non-Direct Phase II FOA to verify Direct Phase II is a valid application type selection. October 2017 Release (NIH) Application Type: Phase II B N N Incl : NIH, FDA, VA Incl: R42, UT2, R44, U44 Provide warning if there is not a previously awarded Phase II, Direct Phase II or Fast Track in the system and the applicant selects Phase IIB on the SBIR/STTR form A previously awarded Phase II, Direct Phase II or Fast Track could not be found. If your project was previously supported by a contract or another agency, contact the eRA Service Desk (). W New Rule October 2017 Release (NIH) Application Type: Phase II B N N Incl : NIH, FDA, VA Incl: R42, UT2, R44, U44 Provide warning when applicant selects Application Type as “New” on the SF424 R&R cover AND selects Phase II B on the SBIR/STTR form Phase II B is not a valid selection when Type of Application selected on the SF 424 R&R Cover is “New”. W New Rule October 2017 Release
eSub-validations-draft-10-10-2017.docx